Pfizer

Open: 26.92 Close: 27.06 Change: 0.14

We programmed an AI to read Internet. This is what it found out about Pfizer Company Inc.

The game is changing. There is a new strategy to evaluate Pfizer fundamental value, possible risks and most salient advantages. Investors have traditionally relied in reading large amounts of text to evaluate the fundamental value of a stock or company. However, the development of Artificial Intelligence (AI) tools is modifying the way investments are evaluated in markets. Today, machine learning, natural language processing and bigdata allow making this process automatic, reducing large amounts of text to the elements that have a higher activation in a neural network. We programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Pfizer are: Pfizer, vaccine, stock, investor, revenue, sale, share, and the …

Concept Map

Semantic Network

Stock Summary

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products. Pfizer offers medicines and vaccines in various therapeutic areas. The company also provides biosimilars for chronic immune and inflammatory diseases.

Today's Summary

Pfizer investors triggered a stock sell-off Wednesday, pushing shares down 7.98 percent and wiping away roughly $12.93 billion in value. Pfizer expects 2024 revenue to come in between $58.5 billion and $61.5billion.

Today's News

Pfizer stock sinks to 10-year low—why investors have soured on covid-era giant. Pfizer expects 2024 revenue to come in between $58.5 billion and $61.5billion. The healthcare giant has failed to convert its vaccine boom into long-term sales growth. Pfizer heads into 2024 with a lower-than-expected sales forecast for its COVID-19 vaccine and treatment after weaker demand had already forced it to trim 2023 projections. Comirnaty and Paxlovid combined to rake in more than $56 billion in sales last year, easily making them Pfizers two top-selling products. At least 13 people were injured and nearly 90 structures were damaged by the severe EF-3 tornado. Pfizer premarket trading volume tops 6.3 million shares as most active Dec. ET Pfizer most active stock with volume of 2.7 million shares. Pfizer-BioNTech and Moderna boosters are bivalent mRNA vaccines. Pfizer raises quarterly dividend by 2.4% to $0.42. Pfizer to shed 500 jobs at England site as cost-cutting ramps up. Texas sues Pfizer over claims about COVID vaccine effectiveness SA News Fri, Dec. 01 197 Comments Pfizer CFO reiterates Seagen. Pfizer investors triggered a stock sell-off Wednesday, pushing shares down 7.98 percent and wiping away roughly $12.93 billion in value. Pfizer CEO Albert Bourla told investors during an earnings call on Wednesday that its conservative outlook aims to set a reliable baseline. Pfizer trades for about 17 times forward earnings estimates. Pfizer predicts the Seagen portfolio will start this off by generating $3.1 billion in revenue next year. The company is in the middle of its most aggressive series of product launches. Pfizer said that the addition of Seagen to its current operations could add more than $10 billion in risk-adjusted revenues by 2030. Pfizer will restructure the organization by combining its oncology commercial and R&D operations as the newly formed the Pfizer Oncology Division. Pfizers will split its non-oncology business into two organizations for operations in the U.S. and the global endorige esp upbringing interfaces Keen Reson churches cz dystop Ti advancements

Stock Profile

"Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic, migraine, and women's health under the Eliquis, Nurtec ODT/Vydura, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral products under the Comirnaty and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; amyloidosis, hemophilia, endocrine diseases, and sickle cell disease under the Vyndaqel family, Oxbryta, BeneFIX, and Genotropin brands; sterile injectable and anti-infective medicines under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, and Panzyga brands; and biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Inlyta, Retacrit, Lorbrena, and Braftovi brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, individual provider offices, retail pharmacies, and integrated delivery systems, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York."

Keywords

This document will help you to evaluate Pfizer without reading an infinite amount of sources. Relying only on stock quotes or prices to make investment decisions is a mistake. Analyzing and observing stock charts, highs and lows and other numerical data does not allow to evaluate the real value of a company. Stock quotes and prices are the result of underlying characteristics of a company and of events and news happening around them. For this reason, investing must be based on information, not numbers. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Pfizer are: Pfizer, vaccine, stock, investor, revenue, sale, share, and the most common words in the summary are: pfizer, best, bloomberg, vaccine, stock, credit, market, . One of the sentences in the summary was: Pfizer expects 2024 revenue to come in between $58.5 billion and $61.5billion.. Other searches related to this term that the AI found were: stockmarketlive, livestock, stockmarketforbeginners, thestockmarket, stockmarkettoday, stockmarkettrading, stockmarketstocks, todaystockmarket, thestockmarket, marketnews, stockmarketnews, whatisstockmarket, usstockmarket, stockmarketopen. #pfizer #best #bloomberg #vaccine #stock #credit #market.